摘要
目的 :研究蕲蛇酶治疗急性脑梗死的临床应用。方法 :将 13 2例患者随机分为两组 ,治疗组应用蕲蛇酶治疗急性脑梗死 72例 ,并与低分子右旋糖酐治疗对照。结果 :蕲蛇酶组基本痊愈 12例 ( 16.7% ) ,显著进步 3 4例 ( 4 7.2 % ) ,进步 18例 ( 2 5 .0 % ) ,总有效率 ( 88.9% ) ,与对照组比较差异极显著 (P <0 .0 1)。结论 :用蕲蛇酶治疗急性脑梗死疗程短 ,无明显不良反应 ,值得临床推广。
Objective:To study of the treatment on the acute cerebral infarction with acutase. Method:A study was conducted in 72 patients with acute cerebral infarction which were treated with acutase and comparing with control group which were treated with low molecular dextran. Results:The result showed that total effective rate of treated group was 88.9% (12 cases) (cured primarily, significant improvent, and improvement),the difference was apparent comparing with the controlled group (P<0.01). Conclusion:The therapy course is shorter with acutase in the treatment of cerebral infarction, there is no apparent adverse reactions.
出处
《医药导报》
CAS
2000年第5期445-446,共2页
Herald of Medicine
关键词
急性脑梗死
药物疗法
蕲蛇酶
治疗
Acutase Low melecular dextran Cerebral infarction,acute
